Trademark: TAVANTA THERAPEUTICS 2146990
Word
TAVANTA THERAPEUTICS
ID
2146990
Trademark Type
Word
Status
Protected: Registered/protected
Application Date
13 November 2020
Registration Date
13 November 2020
Renewal Date
13 November 2030
Owner(s)
Tavanta Therapeutics, Inc.
Service
Goods and Services:
Class 5:
Housemark for a full line of prescription pharmaceuticals for the treatment of cancer, multiple sclerosis, cystic fibrosis, and tuberous sclerosis complex; pharmaceuticals for treatment of cancer, multiple sclerosis, cystic fibrosis, and tuberous sclerosis complex; pharmaceuticals exhibiting efficient drug release for the treatment of cancer, multiple sclerosis, cystic fibrosis, and tuberous sclerosis complex.

Trademark Alertz ® - GRJR PTY LTD 2024 - Privacy Policy - Terms of Use

The information provided on Trademark Alertz is not legal or professional advice. Information may have been obtained from third parties and may contain errors. You must make your own enquiries and seek independent advice from relevant industry professionals before acting or relying on any information from Trademark Alertz. All trade mark information has been obtained from and made publicly available by IP Australia. Copyright of the trademark data resides with IP Australia. ipaustralia.gov.au